Researchers engineered Toxoplasma to deliver a hybrid protein containing MECP2 into neurons, potentially offering a treatment route for brain disorders like Rett syndrome and neurodegenerative diseases like Alzheimer's and Parkinson's disease.
While Toxoplasma delivery of proteins shows promise, the road to clinical use is long. The parasite's potential for lifelong infections and widespread prevalence complicate its medical application.
[
Collection
]
[
|
...
]